Presentation is loading. Please wait.

Presentation is loading. Please wait.

DRAFT Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup August 16, 2013.

Published byAnita Fax Modified over 9 years ago

Similar presentations

Presentation on theme: "DRAFT Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup August 16, 2013."— Presentation transcript:

1 DRAFT Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup August 16, 2013

2 DRAFT August 7 HITPC Meeting High-level summary of feedback received from HITPC: Core Comment AreasFeedback Focus on OutcomesConnect MU3 objectives with outcomes DeemingPositive; review eCQM pipeline and recommendations of QM/ACO TT

3 DRAFT Functional Objective Feedback Stage 3 should clearly signal outcomes – Tie MU3 objectives to outcomes measures – Link to HHS quality strategy (e.g., NQS, Million Hearts) – Link to future payment models (e.g., accountable care organizations) – Consider shifting structure of recommendations to focus on outcomes The use of certification-only criteria should be strategically limited

4 DRAFT Deeming Feedback Deeming concept focuses on achieving good outcomes Appreciate the flexibility of this alternative pathway Need outcomes-oriented eCQMs Must all the data measures come from the EHR? What about claims data?

5 DRAFT Next Steps Address HITPC concerns Provide framework recommendations – Present high level outcomes-driven framework to HITPC at September Meeting – Follow up in Oct or Nov with more detailed recommendations (QM/ACO TT in Oct)

6 DRAFT Recommendations for Presentation to HITPC in September 2013

7 DRAFT Core Recommendations 1.Focus on health and care outcomes 2.Use eCQMs to measure identified care outcomes 3.Incorporate functional deeming as an option for MU3 compliance

8 DRAFT Recommendation 1: Focus on initiatives that help improve care outcomes

9 DRAFT Moving towards outcomes for MU3 MU3 Improved Quality of Care Healthier Living / Disease Prevention Improved Safety Increased Patient Engagement Improved Care Coordination Accessible and Affordable Care

10 DRAFT MU Categories Derived from National Priorities Partnership Goals Work with communities to promote wide use of best practices to enable health living and well-being Improved Quality of Care / Healthier Living Promote the most effective prevention, treatment, and intervention practices for the leading causes of mortality, starting with cardiovascular disease Healthier Living & Disease Prevention Ensure person- and family-centered care Increased Patient Engagement Make care safer Improved Safety Promote effective communication and care coordination Improved Care Coordination Make quality care affordable for people, families, employers, and governments Accessible and Affordable Care National Priorities Partnership Goals MU3 Care Outcomes Align with NPP

11 DRAFT Care Outcome: Improved Quality of Care Stage One CPOE Initial CDS Patient lists Problem lists Meds lists Medication allergies Drug-allergy checks Vitals Lab results Smoking eRx Patient reminders Stage Two CPOE+ CDS+ Patient lists+ Imaging Hospital labs Progress notes Stage Three Recommendation CDS++ Real-time dynamic dashboards (for clinical and population health management) Advanced CDS interventions (e.g., chronic disease management, test ordering, prevention, accuracy of lists) Medication adherence Order tracking (e.g., closing the loop)

12 DRAFT Care Outcome: Healthier Living & Disease Prevention Stage One Immunization PH reporting Patient education Stage Two CDS+ Cancer registry Family history Electronic lab reporting Stage Three Recommendation CDS interventions that use family history CDS interventions to manage chronic conditions

13 DRAFT Care Outcome: Increased Patient Engagement Stage One Clinical summary Online access Patient education Stage Two View, download, transmit Secure messaging Stage Three Recommendation Patient generated health data Communication preferences Amendments

14 DRAFT Care Outcome: Improved Safety Stage One CPOE CDS eRx Medication allergies Medication reconciliation Stage Two CPOE+ CDS+ eMAR Stage Three Recommendation CDS++ Use of Common Formats (e.g., adverse event reports, healthcare associated infections)

15 DRAFT Care Outcome: Improved Care Coordination Stage One Summary of care Stage TwoStage Three Recommendation Health event notification (e.g., ED visit, admission to hospital) Close the referral loop

16 DRAFT Care Outcome: Accessible and Affordable Care for All Stage One Race Ethnicity Language Formulary checks Stage TwoStage Three Recommendation Capture of additional information – Occupation – Sexual orientation and gender identity – Veteran status Capture FDA Unique Device Identifier (UDI)

17 DRAFT Recommendation 2: Use eCQMs to Measure Identified Care Outcomes

18 DRAFT Core Recommendation 2 Use CQMs to Measure Outcomes Improved Quality of Care CV Risks Blood Pressure Control LDL Control Healthier Living/ Disease Prevention Immunization (i.e., flu, pneumonia, childhood vaccinations) Cancer Screening (i.e., colon, prostate, cervical) Improved Safety Falls Pressure Ulcer HAI Morphine Equivalent “Never Give Together” Time in Therapeutic Range for Warfrin Outcomes Proposed eCQMs

19 DRAFT Core Recommendation 2 Use CQMs to Measure Outcomes Increased Patient Engagement Knee Hip Heart Failure (functional status) Improved Care Coordination Close the referral loop Reciprocal referrals Care transitions for hospitals Readmissions Accessible and Affordable Care Choosing Wisely Do not overtreat A1C Reduce CT scans for headache ED throughput MRI back pain Radiation dosing Adherence (reference CBO) Health Improvement Outcomes Proposed eCQMs

20 DRAFT Recommendation 3: Implement Deeming Pathway

21 DRAFT Recommendations on Functional Deeming Providers who have already met all functional objectives in stages 1 and 2 should be allowed to “deem” Deeming allows high MU performers (or significant improvers) to attest for MU by satisfying a subset of MU objectives; this would be an optional pathway to achieve MU “Deeming” promotes innovation, reduces burden, and rewards good performance CMS should survey the landscape for available eCQMs that are outcomes-oriented and consider their use as deeming measures; in addition, new development of eCQMs may be necessary 20

22 DRAFT Next Steps Approve outcomes framework for MU stage 3 MU WG to review objectives for alignment with outcomes framework Receive input on eCQMs from QM/ACO TT (Oct) Present additional recommendations to HITPC in Nov 21

Download ppt "DRAFT Stage 3 Update Paul Tang, Chair George Hripcsak, Co-Chair Meaningful Use Workgroup August 16, 2013."

Similar presentations

2009 HIMSS Analytics Mapping EMRAM and the Ambulatory EMR Adoption Model to Meaningful Use Criteria September 9, 2009 Mike Davis.

2009 HIMSS Analytics Mapping EMRAM and the Ambulatory EMR Adoption Model to Meaningful Use Criteria September 9, 2009 Mike Davis.
Meaningful Use and Health Information Exchange

Meaningful Use and Health Information Exchange
Dedicated to Hope, Healing and Recovery 0 Dec 2009 Interim/Proposed Rules Meaningful Use, Quality Reporting & Interoperability Standards January 10, 2010.

Dedicated to Hope, Healing and Recovery 0 Dec 2009 Interim/Proposed Rules Meaningful Use, Quality Reporting & Interoperability Standards January 10, 2010.
National Quality Strategy Overview August 2013. National Quality Strategy Introduction The Affordable Care Act (ACA) requires the Secretary of the Department.

National Quality Strategy Overview August National Quality Strategy Introduction The Affordable Care Act (ACA) requires the Secretary of the Department.
Quality Measures Vendor Tiger Team December 13, 2013.

Quality Measures Vendor Tiger Team December 13, 2013.
Quality Measures Vendor Tiger Team January 30, 2014.

Quality Measures Vendor Tiger Team January 30, 2014.
Meaningful Use Basics.  Demographics  Active Medication List  Active Allergy List  Vitals  Smoking Status  Problem List  Computerized Physician/Provider.

Meaningful Use Basics.  Demographics  Active Medication List  Active Allergy List  Vitals  Smoking Status  Problem List  Computerized Physician/Provider.
Understanding Meaningful Use Presented by: Allison Bryan MS, CHES December 7, 2012 Purdue Research Foundation 2012 Review of Stage 1 and Stage 2.

Understanding Meaningful Use Presented by: Allison Bryan MS, CHES December 7, 2012 Purdue Research Foundation 2012 Review of Stage 1 and Stage 2.
2014 Certification Criteria associated with MU Menu Stage 2: 2014 Certification Criteria associated with MU Core Stage 2: 2014 Certification Criteria associated.

2014 Certification Criteria associated with MU Menu Stage 2: 2014 Certification Criteria associated with MU Core Stage 2: 2014 Certification Criteria associated.
VISION FOR MEANINGFUL USE. 2 Meaningful Use Workgroup Co-Chairs: Paul Tang, Palo Alto Medical Foundation Farzad Mostashari, New York City Health Department.

VISION FOR MEANINGFUL USE. 2 Meaningful Use Workgroup Co-Chairs: Paul Tang, Palo Alto Medical Foundation Farzad Mostashari, New York City Health Department.
Accountable Care Quality Measures Subgroup October 28, 2013.

Accountable Care Quality Measures Subgroup October 28, 2013.
Meeting Stage 1 Meaningful Use Criterion Carlos A. Leyva, Esq. Digital Business Law Group, P.A. www.digitalbusinesslawgroup.com.

Meeting Stage 1 Meaningful Use Criterion Carlos A. Leyva, Esq. Digital Business Law Group, P.A.
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair October 20,

HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair October 20,
Meaningful Use Workgroup Pathways for Meaningful Use Stage 3 1.

Meaningful Use Workgroup Pathways for Meaningful Use Stage 3 1.
GOVERNMENT EHR FUNDING: MEANINGFUL USE STAGE 2 UPDATE October 25, 2012 Jonathan Krasner Healthcare IT Consultant BEI 571-612-3344.

GOVERNMENT EHR FUNDING: MEANINGFUL USE STAGE 2 UPDATE October 25, 2012 Jonathan Krasner Healthcare IT Consultant BEI
Proposed Meaningful Use Criteria for Stage 2 and 3 John D. Halamka.

Proposed Meaningful Use Criteria for Stage 2 and 3 John D. Halamka.
Meaningful Use, Standards and Certification Under HITECH—Implications for Public Health InfoLinks Community of Practice January 14, 2010 Bill Brand, MPH,

Meaningful Use, Standards and Certification Under HITECH—Implications for Public Health InfoLinks Community of Practice January 14, 2010 Bill Brand, MPH,
HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair December 13,

HIT Policy Committee Meaningful Use Workgroup Paul Tang, Palo Alto Medical Foundation, Chair George Hripcsak, Columbia University, Co- Chair December 13,
Medicare & Medicaid EHR Incentive Programs

Medicare & Medicaid EHR Incentive Programs
Moderator Kevin Larsen, MD Medical Director, Meaningful Use Office of the National Coordinator for Health Information Technology Washington, D.C. Using.

Moderator Kevin Larsen, MD Medical Director, Meaningful Use Office of the National Coordinator for Health Information Technology Washington, D.C. Using.

Similar presentations

Ads by Google